A recent report from the Nigeria Centre for Disease Control and Prevention (NCDC) has revealed a concerning trend in Mpox cases in Nigeria. Since January 2024, males have accounted for 67% of Mpox cases, with children under five years old being the most affected age group.
According to the NCDC, “Men are predominantly affected, accounting for approximately 70% of 6,001 suspected and confirmed Mpox cases recorded in Nigeria since September 2017.” The report also showed that 15 out of 64 confirmed cases in 2024 were children under five.
Mpox, a viral disease caused by the monkeypox virus, can lead to severe symptoms, including painful rash, swollen lymph nodes, and fever. The disease can spread through close contact, respiratory droplets, and contaminated objects.
The World Health Organization (WHO) has declared Mpox a global public health emergency, with cases reported in at least 14 African countries. Nigeria recently received 10,000 doses of Jynneos, a Mpox vaccine, donated by the US government.
Fortunately, no fatalities have been recorded in Nigeria in 2024, compared to two and seven deaths in 2022 and 2023, respectively.
The NCDC’s report highlights the need for increased awareness and vigilance, particularly among high-risk groups. “We must take proactive measures to prevent the spread of Mpox,” said an NCDC official.
The WHO’s approval of the MVA-BN vaccine as the first Mpox vaccine on its prequalification list is a significant step in combating the outbreak.
As Nigeria works to contain the outbreak, the public is urged to take precautions and report any suspected cases to health authorities immediately.
